-
Subject Areas on Research
-
A Novel Strategy to Identify Placebo Responders: Prediction Index of Clinical and Biological Markers in the EMBARC Trial.
-
A comparison of placebo and no-treatment during a hypnotic clinical trial.
-
A double-blind, placebo-controlled trial of four fixed rate infusion regimens of phenylephrine for hemodynamic support during spinal anesthesia for cesarean delivery.
-
A randomized, controlled pilot study of acupuncture treatment for menopausal hot flashes.
-
A randomized, placebo-controlled trial of oxycodone and of gabapentin for acute pain in herpes zoster.
-
A repeated measures model for analysis of continuous outcomes in sequential parallel comparison design studies.
-
Applications of TMS to therapy in psychiatry.
-
Are the clinical effects of homoeopathy placebo effects?
-
Central pain processing in irritable bowel syndrome is modulated by mood: a mechanism for the beneficial effects of antidepressants?
-
Commercial features of placebo and therapeutic efficacy.
-
Comparative "nocebo effects" in older patients enrolled in cancer therapeutic trials: Observations from a 446-patient cohort.
-
Differential response to placebo among patients with social phobia, panic disorder, and obsessive-compulsive disorder.
-
Don't ask, don't tell? Revealing placebo responses to research participants and patients.
-
Dynamic nature of the placebo response.
-
Effect of Apixaban on All-Cause Death in Patients with Atrial Fibrillation: a Meta-Analysis Based on Imputed Placebo Effect.
-
Effect of Etelcalcetide vs Placebo on Serum Parathyroid Hormone in Patients Receiving Hemodialysis With Secondary Hyperparathyroidism: Two Randomized Clinical Trials.
-
Effect of apixaban, an oral and direct factor Xa inhibitor, on coagulation activity biomarkers following acute coronary syndrome.
-
Effectiveness of blinding: sham suprapubic incisions in a randomized trial of retropubic midurethral sling in women undergoing vaginal prolapse surgery.
-
Effects of Once-Weekly Exenatide on Clinical Outcomes in Patients With Preexisting Cardiovascular Disease.
-
Effects of blackcurrant anthocyanin intake on peripheral muscle circulation during typing work in humans.
-
Efficacy and safety of donepezil in patients with schizophrenia or schizoaffective disorder: significant placebo/practice effects in a 12-week, randomized, double-blind, placebo-controlled trial.
-
Ethical considerations in design of a study to evaluate a US Food and Drug Administration-approved indication: antivenom versus placebo for copperhead envenomation.
-
Expectancy Reduces Symptoms but not Functional Impairment Following Exercise-induced Musculoskeletal Injury.
-
Extended-release carbamazepine capsules as monotherapy for acute mania in bipolar disorder: a multicenter, randomized, double-blind, placebo-controlled trial.
-
Extended-release carbamazepine capsules as monotherapy in bipolar disorder : pooled results from two randomised, double-blind, placebo-controlled trials.
-
From Bench to Bedside: Converting Placebo Research into Belief Activation.
-
Healthy users, healthy adherers, and healthy behaviors?
-
Improvement in the mechanical efficiency of walking: an explanation for the "placebo effect" seen during repeated exercise testing of patients with heart failure. Duke University Clinical Cardiology Studies (DUCCS) Exercise Group.
-
Magnitude of placebo response and drug-placebo differences across psychiatric disorders.
-
Meta-analysis of pain and function placebo responses in pharmacological osteoarthritis trials.
-
Migraine therapeutics in adolescents: a systematic analysis and historic perspectives of triptan trials in adolescents.
-
National Depressive and Manic-Depressive Association consensus statement on the use of placebo in clinical trials of mood disorders.
-
Pharmacometabolomic mapping of early biochemical changes induced by sertraline and placebo.
-
Placebo Response Rates in Trials of Licensed Drugs for Irritable Bowel Syndrome With Constipation or Diarrhea: Meta-analysis.
-
Placebo Response and Practice Effects in Schizophrenia Cognition Trials.
-
Placebo Response in Pediatric Anxiety Disorders: Results from the Child/Adolescent Anxiety Multimodal Study.
-
Placebo effect in chronic inflammatory demyelinating polyneuropathy: The PATH study and a systematic review.
-
Placebo response mitigation with a participant-focused psychoeducational procedure: a randomized, single-blind, all placebo study in major depressive and psychotic disorders.
-
Placebo response rate in clinical trials of fistulizing Crohn's disease: systematic review and meta-analysis.
-
Prevention of Stroke with the Addition of Ezetimibe to Statin Therapy in Patients With Acute Coronary Syndrome in IMPROVE-IT (Improved Reduction of Outcomes: Vytorin Efficacy International Trial).
-
Quantitative sensory testing in predicting persistent pain after joint replacement surgery: promise and challenges.
-
Randomness, attributions of arousal, and belief in god.
-
Redefined Measure of Early Neurological Improvement Shows Treatment Benefit of Alteplase Over Placebo.
-
Response characteristics to antidepressants and placebo in post-traumatic stress disorder.
-
Results of the FUEL Trial.
-
Safety and Tolerability of CSL112, a Reconstituted, Infusible, Plasma-Derived Apolipoprotein A-I, After Acute Myocardial Infarction: The AEGIS-I Trial (ApoA-I Event Reducing in Ischemic Syndromes I).
-
Safety and efficacy of cangrelor, an intravenous, short-acting platelet inhibitor in patients requiring coronary artery bypass surgery.
-
Safety and efficacy of flecainide in subjects with Long QT-3 syndrome (DeltaKPQ mutation): a randomized, double-blind, placebo-controlled clinical trial.
-
Safety, pharmacokinetics, and immunogenicity of the combination of the broadly neutralizing anti-HIV-1 antibodies 3BNC117 and 10-1074 in healthy adults: A randomized, phase 1 study.
-
Sample size requirements and length of study for testing interaction in a 2 x k factorial design when time-to-failure is the outcome [corrected].
-
Selecting methodologies for the evaluation of differences in time to response between antidepressants.
-
The Alzheimer's Disease Assessment Scale: evaluation of psychometric properties and patterns of cognitive decline in multicenter clinical trials of mild to moderate Alzheimer's disease.
-
The control group dilemma in clinical research: applications for psychosocial and behavioral medicine trials.
-
The potential of a placebo/nocebo effect in pharmacogenetics.
-
The so-called "placebo effect" in benign prostatic hyperplasia treatment trials represents partially a conditional regression to the mean induced by censoring.
-
Unanticipated Insights into Biomedicine from the Study of Acupuncture.
-
Viscoelastic testing to assess the effects of rapid fibrinogen concentrate administration after cardiopulmonary bypass: insights from the REPLACE study.
-
Keywords of People